Matches in Nanopublications for { ?s ?p "Regadenoson is an A2A adenosine receptor agonist that causes coronary vasodilation and used for myocardial perfusion imagining. Manufactured by Astellas and FDA approved April 10, 2008."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.